CNA Financial’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-16,720
| Closed | -$241K | – | 164 |
|
|
2022
Q3 | $241K | Sell |
16,720
-7,190
| -30% | -$104K | 0.09% | 154 |
|
|
2022
Q2 | $362K | Sell |
23,910
-1,540
| -6% | -$23.3K | 0.13% | 149 |
|
|
2022
Q1 | $302K | Buy |
25,450
+7,220
| +40% | +$85.7K | 0.09% | 173 |
|
|
2021
Q4 | $296K | Buy |
18,230
+4,470
| +32% | +$72.6K | 0.08% | 181 |
|
|
2021
Q3 | $393K | Buy |
13,760
+470
| +4% | +$13.4K | 0.11% | 176 |
|
|
2021
Q2 | $449K | Buy |
13,290
+910
| +7% | +$30.7K | 0.13% | 171 |
|
|
2021
Q1 | $374K | Buy |
12,380
+1,600
| +15% | +$48.3K | 0.11% | 177 |
|
|
2020
Q4 | $534K | Buy |
10,780
+890
| +9% | +$44.1K | 0.17% | 151 |
|
|
2020
Q3 | $380K | Buy |
9,890
+600
| +6% | +$23.1K | 0.14% | 155 |
|
|
2020
Q2 | $401K | Buy |
+9,290
| New | +$401K | 0.16% | 147 |
|